Sarilumab for the Treatment of Moderate-to-Severe Rheumatoid Arthritis: Results of a Phase 2, Randomized, Double-Blind, Placebo-Controlled, International Study Genovese, M. C., Kivitz, A. J., Simon Campos, J., Rell-Bakalarska, M., Fleischmann, R. M., Jasson, M., Radin, A. R., Huang, X., Huizinga, T. J. WILEY-BLACKWELL. 2011: 4041–42

View details for Web of Science ID 000297458500060